U.S. researchers have engineered mice that model the mechanisms of three relatively common genetic causes of autism spectrum disorder, making it possible to undertake phenotypic screening for therapeutics. Behavioral and neurophysiological assays now are needed to relate the animal abnormalities to clinical disease.